Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a46f1eeddab9c13223203339da7d859b |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-702 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7034 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7034 |
filingDate |
2019-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ee658b314b81ec4b121b807ee28b460 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0583415a1fe9ea79711a6b168fd9348 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c262414456da9863177def04db1711fb |
publicationDate |
2021-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
BR-112020018184-A2 |
titleOfInvention |
compound uses |
abstract |
methods for treating or inhibiting cancer and / or one or more related conditions by administering to an individual in need of an efficient amount of a compound of the formula (i) a prodrug thereof or a pharmaceutically acceptable salt of any one of the previous ones. for example, methods for treating aml, mds, neutropenia and / or mucositis are described which comprise the administration of a pharmaceutical composition comprising a compound of the formula (i). |
priorityDate |
2018-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |